📷 Image: TOI India (via NewsData)
Health
India cuts TB deaths by 38% since 2015, treatment success hits 94%
✍️ TOI India
🗓 13 Nov 2026, 08:48 AM
👁 14
The Centre announced that India has reduced TB-related deaths by 38% between 2015 and 2025. The TB Mukt Bharat Abhiyaan identified nearly 15 lakh asymptomatic cases, boosting the treatment success rate to 94%.
The Government of India has reported significant progress in the fight against tuberculosis, stating that estimated TB deaths have declined by 38% between 2015 and 2025. This reduction signals a major step forward in controlling the disease, which has long been a leading cause of mortality in the country.
According to the Centre, the treatment success rate for drug-susceptible TB has reached an impressive 94%. This achievement is attributed to the adoption of innovative diagnostic methods and the provision of comprehensive patient care across the nation.
A key driver of this progress has been the TB Mukt Bharat Abhiyaan, which effectively identified nearly 15 lakh asymptomatic TB cases throughout the campaign. Early detection of these silent cases has allowed for timely intervention and better health outcomes.
Despite these gains, authorities acknowledge that drug-resistant TB remains a persistent challenge. There is still a notable treatment gap in managing resistant strains, requiring continued focus and resource allocation to ensure complete elimination of the disease.
According to the Centre, the treatment success rate for drug-susceptible TB has reached an impressive 94%. This achievement is attributed to the adoption of innovative diagnostic methods and the provision of comprehensive patient care across the nation.
A key driver of this progress has been the TB Mukt Bharat Abhiyaan, which effectively identified nearly 15 lakh asymptomatic TB cases throughout the campaign. Early detection of these silent cases has allowed for timely intervention and better health outcomes.
Despite these gains, authorities acknowledge that drug-resistant TB remains a persistent challenge. There is still a notable treatment gap in managing resistant strains, requiring continued focus and resource allocation to ensure complete elimination of the disease.